Immune system – non-molecular vaccine-mediated priming

Immune system – non-molecular vaccine-mediated priming is not a specific molecular target but rather a physiological process more accurately described as trained immunity or the non-specific effects of vaccines. This phenomenon involves the functional reprogramming of innate immune cells, such as monocytes, macrophages, and natural killer (NK) cells, following exposure to certain stimuli like the BCG vaccine or beta-glucans (Netea et al., 2020, Science). Unlike traditional vaccine-mediated immunity, which relies on antigen-specific B and T cell responses, this priming mechanism provides broad protection against a variety of pathogens through epigenetic modifications and metabolic rewiring (Benn et al., 2013, Trends in Immunology). While not a single receptor or enzyme, this process is a significant area of research for improving vaccine efficacy and developing novel immunotherapies for infectious diseases and cancer (Chumakov et al., 2020, Science). The term 'non-molecular' in this context is likely a mischaracterization of 'non-specific' or 'innate-mediated' priming. Clinical applications are currently being explored to leverage these pathways for pandemic preparedness and oncology, though the non-specific nature of the response carries theoretical risks of hyper-inflammation or autoimmunity.

Other names

Trained immunityNon-specific effects of vaccines (NSEs)Innate immune memoryHeterologous immunityNon-specific vaccine-mediated priming

Induction of epigenetic modifications (e.g., histone methylation) and metabolic shifts (e.g., increased glycolysis) in innate immune cells to enhance responsiveness to future unrelated stimuli.